Skip to main content
. 2021 Nov 4;8:747453. doi: 10.3389/fcvm.2021.747453

Table 3.

Extracellular vesicle (EV) concentration and percentage [%] of Annexin V+ EV in patients with ST-elevation myocardial infarction (STEMI) with either normal-lightly (≥40 %) or moderately-severely (<40 %) reduced left ventricular ejection fraction (LVEF).

Parameter LVEF ≥ 40 % (n = 15) LVEF <40 % (n = 4) p-value
Total Annexin V+ EV/ml 57,145 ± 10,360 82,498 ± 26,057 0.30
CD61+ EV/ml 7,499 ± 1,408 4,687 ± 645.6 0.33
Caveolin-3+ EV/ml 2,819 ± 776.6 8,992 ± 4,425 0.03
CD45+ EV/ml 300.0 ± 230.9 236.7 ± 219.6 0.89
CD62E+ EV/ml 304.2 ± 121.7 449.1 ± 123.0 0.56
CD235a+ EV/ml 29,281 ± 5,687 42,353 ± 14,021 0.33
CD61+ EV [%] 19.0 ± 4.7 7.0 ± 1.8 0.21
Caveolin-3+ EV [%] 5.0 ± 0.9 9.8 ± 4.7 0.11
CD45+ EV [%] 1.1 ± 1.0 0.3 ± 0.2 0.68
CD62E+ EV [%] 0.6 ± 0.2 0.7 ± 0.2 0.84
CD235a+ EV [%] 53.8 ± 5.3 52.8 ± 12.2 0.93

CD61+ (platelet) EV, caveolin-3+ (cardiomyocyte) EV, CD45+ (leukocyte) EV, CD62E+ (endothelial) EV, CD235a+ (erythrocyte) EV. LVEF was obtained from the first echocardiography performed by a specialist after STEMI, usually 2-4 days after the event. Data are presented as mean±SEM. p-values were calculated by an unpaired Student's t-test. Significant p-values are indicated in bold.